Singapore markets closed
Straits Times Index
3,296.89 +4.20 (+0.13%) S&P 500
5,023.39 +5.00 (+0.10%) Dow
37,988.61 +85.32 (+0.23%) Nasdaq
15,664.09 +58.61 (+0.38%) Bitcoin USD
59,258.44 +2,011.11 (+3.51%) CMC Crypto 200
1,264.97 -5.77 (-0.45%)
Galera Therapeutics, Inc. (GRTX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 10:45AM EDT. Market open.
| Previous close | 0.1898 |
| Open | 0.1852 |
| Bid | 0.1901 x 200 |
| Ask | 0.2025 x 200 |
| Day's range | 0.1852 - 0.2040 |
| 52-week range | 0.0850 - 3.5900 |
| Volume | |
| Avg. volume | 2,067,144 |
| Market cap | 10.71M |
| Beta (5Y monthly) | 2.17 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Galera Therapeutics Insiders Lose Out As Stock Sinks To US$0.17
The recent 19% drop in Galera Therapeutics, Inc.'s ( NASDAQ:GRTX ) stock could come as a blow to insiders who purchased...
- Zacks
All You Need to Know About Galera Therapeutics, Inc. (GRTX) Rating Upgrade to Buy
Galera Therapeutics, Inc. (GRTX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks
Biotech Stock Roundup: SAGE, GRTX Plunge on Setback, REGN to Buy DBTX & More News
Regulatory updates from SAGE and Galera (GRTX) are in focus in the biotech sector.
© 2024 Yahoo. All rights reserved.